default author photo

John A. Snowden

Sheffield Teaching Hospitals NHS Foundation Trust

Robert Hadfield Building

Northern General Hospital

Sheffield, S5 7AU

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

242

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Immunogenicity of SARSCoV2 Third Dose Vaccine Strategies in Immunocompromised Patients with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): An Open-Label, Multi-Centre, Randomised, Controlled Phase III Trial

Number of pages: 50 Posted: 10 Nov 2023
University of Glasgow, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London, University of Glasgow, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Southampton University, University of Birmingham, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Wellcome Trust Centre for Human Genetics, The Francis Crick Institute, Francis Crick Institute - Cell Biology of Infection Laboratory, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Oxford - Nuffield Department of Medicine, University of Oxford, Mahidol University - Mahidol-Oxford Tropical Medicine Research Unit, University of Leeds, Guy's Hospital - British Society of Blood and Marrow Transplantation and Cellular Therapy, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Oxford, University College London - Research Department of Hematology, University of Leicester - Leicester General Hospital, University of London - Institute of Infection and Immunity, Royal Free Hospital, University of Southampton - University Hospital Southampton NHS Foundation Trust, University of Glasgow - College of Medical, Veterinary & Life Sciences, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Imperial College Healthcare NHS Trust, University of Oxford - Nuffield Department of Medicine, University of Southampton - University Hospital Southampton NHS Foundation Trust, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Glasgow - College of Medical, Veterinary & Life Sciences, Imperial College London, Imperial College London, University of Birmingham, University of Glasgow and University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences
Downloads 130 (569,079)

Abstract:

Loading...

COVID-19, Immunology, Clinical trial, Vaccine

2.

Continuous and Differential Improvement in Worldwide Access to Hematopoietic Cell Transplantation: Notable Increase of HCT for Non-Malignant Indications and from Non-Identical Related Donors

Number of pages: 39 Posted: 13 Dec 2023
Japanese Data Center for Hematopoietic Cell Transplantation, University of Basel - University Hospital Basel, University of Leipzig - Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Barcelona - Department of Haematology, Medical College of Wisconsin - Center for International Blood and Marrow Transplant Research (CIBMTR), Aichi Medical University, Las Américas Auna - Instituto de Cancerología, The University of Western Australia - Fiona Stanley Hospital, Cairo University - National Cancer Institute, University of Benin - University of Benin Teaching Hospital, Pelé Pequeno Príncipe Research Institute, Hospital de la Princesa - Hematology Department, King Faisal Specialist Hospital and Research Centre - Oncology Center, Università Vita-Salute San Raffaele - San Raffaele Hospital, Hospital Israelita Albert Einstein, Instituto de Previsión Social, British Hospital, Sorbonne-Université, Hospital Civil de Guadalajara «Dr. Juan I. Menchaca», Università Vita-Salute San Raffaele - San Raffaele Hospital, Monash University, University of Amsterdam, Academic Medical Center, Department of Hematology, Medical College of Wisconsin, Wroclaw Medical University, National Taiwan University - National Taiwan University Hospital (NTUH), Aichi Medical University, University of London - Institute of Infection and Immunity, Peking University - Institute of Hematology, University College London - University College London Hospitals NHS Foundation Trust, Kyungpook National University - Kyungpook National University Hospital, Hôpital Necker-Enfants Malades, Keio University - School of Medicine, Medical College of Wisconsin, University of Manitoba, University of Illinois at Chicago, San Raffaele Institute, Federal University of São Paulo (UNIFESP) - Paulista School of Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Christian Medical College - Department of Clinical Hematology, Peter MacCallum Cancer Centre, The University of Minnesota - Division of Hematology, Medical University of Vienna, Medical University of Graz, Medical College of Wisconsin - Center for International Blood and Marrow Transplant Research (CIBMTR), King Faisal Specialist Hospital and Research Centre - Oncology Center, University of Leipzig and Independent
Downloads 112 (635,507)

Abstract:

Loading...

Hematopoietic Cell Transplantation, Access to HCT, Worldwide Network of Blood and Marrow Transplantation